论文部分内容阅读
目的探讨依达拉奉联合奥扎格雷钠治疗急性脑梗死的临床效果。方法选择我院2009年11月至2011年11月急性脑梗死患者100例,分为观察组和对照组。两组患者均给予常规治疗,观察组同时给予依达拉奉和奥扎格雷钠,对照组给予奥扎格雷钠。根据卒中临床神经功能缺损评定标准(NIHSS)和日常生活能力(Barthel指数)对两组患者治疗前和治疗后进行评定。结果观察治疗后神经功能缺损评分及日常生活能力评分分别与对照组治疗比较,差异有统计意义(P<0.05)。观察组总有效率显著高于对照组,差异有统计学意义(P<0.05)。结论依达拉奉联合奥扎格雷钠能够显著改善急性脑梗死患者神经功能缺损症状及日常生活能力,临床效果显著。
Objective To investigate the clinical efficacy of edaravone combined with ozagrel sodium in the treatment of acute cerebral infarction. Methods 100 cases of acute cerebral infarction in our hospital from November 2009 to November 2011 were selected and divided into observation group and control group. Two groups of patients were given conventional treatment, the observation group were given edaravone and ozagrel sodium, while the control group given ozagrel sodium. The two groups of patients were assessed before and after treatment according to the criteria of NIHSS and Barthel index. Results After treatment, the neurological deficit score and daily living ability score were respectively compared with the control group, the difference was statistically significant (P <0.05). The total effective rate of the observation group was significantly higher than that of the control group, the difference was statistically significant (P <0.05). Conclusion Edaravone combined with ozagrel sodium can significantly improve the symptoms and daily living ability of patients with acute cerebral infarction. The clinical effect is significant.